Genmark Diagnostics reported $44.13M in Current Liabilities for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Accelerate Diagnostics AXDX:US 7.51M 1.81M
Agilent A:US $ 1708M 16M
Bruker BRKR:US $ 919.5M 35.1M
Danaher DHR:US $ 7257M 432M
Exact Sciences EXAS:US $ 710.23M 34.53M
Genmark Diagnostics GNMK:US $ 44.13M 3.46M
Hologic HOLX:US $ 1326.8M 137.8M
Illumina ILMN:US $ 914M 40M
Laboratory Of America LH:US $ 2888.4M 221.3M
Luminex LMNX:US $ 57.56M 29.9M
Mesa Laboratories MLAB:US $ 28.69M 4.76M
Myriad Genetics MYGN:US $ 203.2M 67.8M
Nanostring Technologies NSTG:US $ 44.48M 1.36M
Orasure Technologies OSUR:US $ 54.17M 7.6M
Oxford Immunotec Global OXFD:US $ 11.8M 0.99M
Pacific Biosciences Of California PACB:US $ 121.08M 75.65M
Perkinelmer PKI:US $ 1145.03M 22.21M
Quest Diagnostics DGX:US $ 1759M 208M
Quidel QDEL:US $ 297.09M 87.82M
Siemens SIE:GR € 39952M 257M
Thermo Fisher Scientific TMO:US $ 7753M 828M
Veracyte VCYT:US $ 50.04M 13.93M
Waters WAT:US $ 1613.62M 932.6M